Analysis

Gri Bio, Inc. (GRI) Stock Analysis

Gri Bio, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to GRI.

websiteGRI/analysis/GRI

Gri Bio, Inc.

Gri Bio, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to GRI.

Stock profile

Ticker

GRI

Asset type

Stock

Market cap

$3.3M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Gri Bio, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • GRI primary listing

Latest Gri Bio, Inc. news

GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis

Designation highlights significant regulatory milestone and provides a potential pathway to seven years of U.S. market exclusivity LA JOLLA, CA, June 18, 2026 (GLOBE NEWSWIRE) -...

GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase

Live webcast fireside chat with Marc Hertz, PhD, Chief Executive Officer, on Wednesday, May 20, 2026 Register for the event here LA JOLLA, CA, May 18, 2026 (GLOBE NEWSWIRE) -- G...

GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Infl...

Issued claims further strengthen global intellectual property portfolio supporting immune cell modulation platform and expand strategic presence in a high-growth international m...

GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment

Access the “What This Means” segment here LA JOLLA, CA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advan...

GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

– Live video webcast on Wednesday, February 11th at 1:00 PM EST LA JOLLA, CA, Feb. 05, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biote...

Research sections

Valuation

Review valuation context for Gri Bio, Inc..

Future growth

Review future growth context for Gri Bio, Inc..

Past performance

Review past performance context for Gri Bio, Inc..

Financial health

Review financial health context for Gri Bio, Inc..

Dividend

Review dividend context for Gri Bio, Inc..

Management

Review management context for Gri Bio, Inc..

Ownership

Review ownership context for Gri Bio, Inc..

Other information

Review other information context for Gri Bio, Inc..

Community

Review community context for Gri Bio, Inc..